Bridge Analytics connects fragmented research data to accelerate breakthroughs that deliver meaningful clinical advancements for patients with Parkinson's, bipolar disorder, autism, and other central nervous system (CNS) conditions.
Our team tackles big challenges in neuroscience and drives progress in fundamental discovery, biomarker development, therapeutics, and assistive technology. We’re building a cutting-edge data ecosystem that makes it easier to find, access, and analyze data generated through CNS research. We provide consulting services that enable our partners to design studies that leverage the latest advances in technology with confidence. We are creating new models of collaboration that unite experts in CNS conditions with leaders in data science on a shared quest to discover cures.
Accelerate the number of CNS therapies treating the right people at the right time by developing the analytic ecosystem that makes it easier to access and analyze biomedical research data.
We believe in a future in which a deep biological understanding of CNS conditions enables patients to receive personalized care that significantly lessens the burden of these diseases.
The development of therapeutic solutions for these and other CNS conditions will take more than any one team can do alone. It will take all of us—doctors, clinicians, researchers, data scientists, and data engineers—working together against a shared set of goals. That collaboration becomes impossible without the right data strategy and supporting infrastructure. Bridge Analytics is developing both the technical ecosystem and the partnership model that leverages it to drive impact.
We make it easy to find, access, and analyze the data collected across CNS research initiatives. More than just a data repository—we ensure that the power to analyze lives alongside the data, letting researchers get to answers more quickly.
We enable people with deep biological and clinical expertise to partner with experts in quantitative analytic approaches and execute targeted research projects.
Dr. Ritu Kapur is a systems neuroscientist with over 18 years of experience in neurodegenerative disease, medical device development, neuromodulation, and signal processing. She has built teams and developed products that leverage traditional and machine-learning methods to extract clinically relevant information from high-density datasets. Most recently, Ritu founded and led Digital Biomarkers at Verily, a team of over 100 scientists, engineers, and operations professionals.
Dr. Ritu Kapur is a systems neuroscientist with over 18 years of experience in neurodegenerative disease, medical device development, neuromodulation, and signal processing. She has built teams and developed products that leverage traditional and machine-learning methods to extract clinically relevant information from high-density datasets. Most recently, Ritu founded and led Digital Biomarkers at Verily, a team of over 100 scientists, engineers, and operations professionals.
Dr. Ritu Kapur is a systems neuroscientist with over 18 years of experience in neurodegenerative disease, medical device development, neuromodulation, and signal processing. She has built teams and developed products that leverage traditional and machine-learning methods to extract clinically relevant information from high-density datasets. Most recently, Ritu founded and led Digital Biomarkers at Verily, a team of over 100 scientists, engineers, and operations professionals.
Dr. Ritu Kapur is a systems neuroscientist with over 18 years of experience in neurodegenerative disease, medical device development, neuromodulation, and signal processing. She has built teams and developed products that leverage traditional and machine-learning methods to extract clinically relevant information from high-density datasets. Most recently, Ritu founded and led Digital Biomarkers at Verily, a team of over 100 scientists, engineers, and operations professionals.
Dr. Ritu Kapur is a systems neuroscientist with over 18 years of experience in neurodegenerative disease, medical device development, neuromodulation, and signal processing. She has built teams and developed products that leverage traditional and machine-learning methods to extract clinically relevant information from high-density datasets. Most recently, Ritu founded and led Digital Biomarkers at Verily, a team of over 100 scientists, engineers, and operations professionals.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
-01.png)
